The Changes of Graft Survival and Causes of Graft Failure after Kidney Transplantation.
10.4285/jkstn.2011.25.1.22
- Author:
Eunah HWANG
1
;
Mihyun JANG
;
Chunghwan KWAK
;
Seungyeup HAN
;
Sungbae PARK
;
Hyunchul KIM
;
Hyoungtae KIM
;
Wonhyun CHO
Author Information
1. Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea. dki@dsmc.or.kr
- Publication Type:Original Article
- Keywords:
Kidney transplantation;
Death;
Graft survival;
Graft rejection;
Risk factors;
Time factors;
Treatment outcome
- MeSH:
Compliance;
Glomerulonephritis;
Graft Rejection;
Graft Survival;
Humans;
Immunosuppression;
Immunosuppressive Agents;
Incidence;
Kidney;
Kidney Transplantation;
Male;
Multivariate Analysis;
Mycophenolic Acid;
Rejection (Psychology);
Risk Factors;
Tacrolimus;
Time Factors;
Tissue Donors;
Transplantation, Homologous;
Transplants;
Treatment Outcome
- From:The Journal of the Korean Society for Transplantation
2011;25(1):22-30
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The incidence of acute rejection has decreased with the introduction of new immunosuppressive agents. However, several studies have shown that allograft survival has not clearly improved over the past few decades. METHODS: We reviewed patients who underwent kidney transplantation between 1982 and 2007. We compared the causes of graft loss for three decades: 1982~1990 (period I),1991~2000 (period II), and 2001~2007 (period III), with the clinical characteristics of patients with functioning grafts and patients who lost their allografts. RESULTS: There were 785 recipients with a mean age of 36.1 years, and 65.2% were male. Graft loss occurred in 329 patients (41.9%), and the most common cause of graft loss was chronic allograft nephropathy (CAN, 52.0%), followed by patient death (17.6%), post-transplant glomerulonephritis (12.8%), and non compliance (7.9%). During the three time periods, 129, 172, and 28 patients lost their grafts, respectively. Five-year graft survival was 61.5%, 78.4%, and 90.8%, respectively, and increased significantly (P<0.000). CAN, as a cause of graft loss, fell from 65.1% (period I) to 32.1% (period III, P<0.000), but patient death increased from 12.4% to 32.1% (P=0.034). A multivariate analysis revealed that significant risk factors for graft loss included an older donor, transplantation at period I, and dual immunosuppression. Use of tacrolimus and mycophenolate mofetil was associated with a significantly reduced risk of graft loss. CONCLUSIONS: Graft survival has increased over the last three decades whereas the proportion of CAN, the most common cause of graft loss, has decreased. Attention to the main causes of graft loss, CAN, and patient death will offer potential improvement in graft survival.
